Trial record 1 of 106 for:    Melanoma (women OR woman OR female)
Previous Study | Return to List | Next Study

Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00745862
First received: August 22, 2008
Last updated: July 23, 2013
Last verified: July 2013
  Purpose

The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.


Condition Intervention
Melanoma
Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • To measure illness related distress regarding survival, family planning and functioning, and aesthetic satisfaction and QOL in post-surgical female patients diagnosed with clinically localized primary cutaneous melanoma. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To examine the impact of illness related distress on QOL in women treated for clinically localized primary cutaneous melanoma. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]

Enrollment: 118
Study Start Date: August 2008
Study Completion Date: July 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment
Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
This pilot study will measure illness related distress in female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment. Areas of particular focus will be survival anxiety, family functioning/childbearing concerns, and aesthetic impact of surgery. Patients will complete a one time only set of quality of life assessments these questionnaires will take 30-45 minutes to complete.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Female melanoma patients during their regularly scheduled surgical clinic appointment at MSKCC.

Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Clinically node-negative primary cutaneous melanoma.
  • Patients participating must be female
  • Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry.

Exclusion Criteria:

  • Prior history of cancer with the exception of squamous or basal cell carcinoma of the skin.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00745862

Locations
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Investigators
Principal Investigator: Mary Sue Brady, MD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided by Memorial Sloan-Kettering Cancer Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00745862     History of Changes
Other Study ID Numbers: 08-096
Study First Received: August 22, 2008
Last Updated: July 23, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Skin

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on August 21, 2014